These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 37716372)

  • 1. Machine learning for individualized prediction of hepatocellular carcinoma development after the eradication of hepatitis C virus with antivirals.
    Minami T; Sato M; Toyoda H; Yasuda S; Yamada T; Nakatsuka T; Enooku K; Nakagawa H; Fujinaga H; Izumiya M; Tanaka Y; Otsuka M; Ohki T; Arai M; Asaoka Y; Tanaka A; Yasuda K; Miura H; Ogata I; Kamoshida T; Inoue K; Nakagomi R; Akamatsu M; Mitsui H; Fujie H; Ogura K; Uchino K; Yoshida H; Hanajiri K; Wada T; Kurai K; Maekawa H; Kondo Y; Obi S; Teratani T; Masaki N; Nagashima K; Ishikawa T; Kato N; Yotsuyanagi H; Moriya K; Kumada T; Fujishiro M; Koike K; Tateishi R
    J Hepatol; 2023 Jun; ():. PubMed ID: 37716372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Personalized surveillance for hepatocellular carcinoma in cirrhosis - using machine learning adapted to HCV status.
    Audureau E; Carrat F; Layese R; Cagnot C; Asselah T; Guyader D; Larrey D; De Lédinghen V; Ouzan D; Zoulim F; Roulot D; Tran A; Bronowicki JP; Zarski JP; Riachi G; Calès P; Péron JM; Alric L; Bourlière M; Mathurin P; Blanc JF; Abergel A; Chazouillères O; Mallat A; Grangé JD; Attali P; d'Alteroche L; Wartelle C; Dao T; Thabut D; Pilette C; Silvain C; Christidis C; Nguyen-Khac E; Bernard-Chabert B; Zucman D; Di Martino V; Sutton A; Pol S; Nahon P;
    J Hepatol; 2020 Dec; 73(6):1434-1445. PubMed ID: 32615276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of machine learning models for predicting prognosis and guiding individualized postoperative chemotherapy: A real-world study of distal cholangiocarcinoma.
    Wang D; Pan B; Huang JC; Chen Q; Cui SP; Lang R; Lyu SC
    Front Oncol; 2023; 13():1106029. PubMed ID: 37007095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel machine learning models outperform risk scores in predicting hepatocellular carcinoma in patients with chronic viral hepatitis.
    Wong GL; Hui VW; Tan Q; Xu J; Lee HW; Yip TC; Yang B; Tse YK; Yin C; Lyu F; Lai JC; Lui GC; Chan HL; Yuen PC; Wong VW
    JHEP Rep; 2022 Mar; 4(3):100441. PubMed ID: 35198928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Machine Learning-Based Personalized Prediction of Hepatocellular Carcinoma Recurrence After Radiofrequency Ablation.
    Sato M; Tateishi R; Moriyama M; Fukumoto T; Yamada T; Nakagomi R; Kinoshita MN; Nakatsuka T; Minami T; Uchino K; Enooku K; Nakagawa H; Shiina S; Ninomiya K; Kodera S; Yatomi Y; Koike K
    Gastro Hep Adv; 2022; 1(1):29-37. PubMed ID: 39129938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Application value of machine learning algorithms for predicting recurrence after resection of early-stage hepatocellular carcinoma].
    Ji GW; Wang K; Xia YX; Li XC; Wang XH
    Zhonghua Wai Ke Za Zhi; 2021 Aug; 59(8):679-685. PubMed ID: 34192861
    [No Abstract]   [Full Text] [Related]  

  • 7. GES: A validated simple score to predict the risk of HCC in patients with HCV-GT4-associated advanced liver fibrosis after oral antivirals.
    Shiha G; Waked I; Soliman R; Elbasiony M; Gomaa A; Mikhail NNH; Eslam M
    Liver Int; 2020 Nov; 40(11):2828-2833. PubMed ID: 32946647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A machine learning model to predict liver-related outcomes after the functional cure of chronic hepatitis B.
    Hur MH; Yip TC; Kim SU; Lee HW; Lee HA; Lee HC; Wong GL; Wong VW; Park JY; Ahn SH; Kim BK; Kim HY; Seo YS; Shin H; Park J; Ko Y; Park Y; Lee YB; Yu SJ; Lee SH; Kim YJ; Yoon JH; Lee JH
    J Hepatol; 2024 Aug; ():. PubMed ID: 39218223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of hepatocellular carcinoma in Hepatitis C patients with advanced fibrosis after sustained virologic response.
    Azzi J; Dorival C; Cagnot C; Fontaine H; Lusivika-Nzinga C; Leroy V; De Ledinghen V; Tran A; Zoulim F; Alric L; Gournay J; Bronowicki JP; Decaens T; Riachi G; Mikhail N; Soliman R; Shiha G; Pol S; Carrat F; Ganne-Carrié N;
    Clin Res Hepatol Gastroenterol; 2022; 46(6):101923. PubMed ID: 35405354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and validation of risk prediction model for hepatocellular carcinoma development after sustained virological response in patients with chronic hepatitis C.
    Chun HS; Kim BK; Park JY; Kim DY; Ahn SH; Han KH; Lee CH; Lee YB; Cho EJ; Yu SJ; Kim YJ; Yoon JH; Lee JH; Kim SU
    Eur J Gastroenterol Hepatol; 2020 Mar; 32(3):378-385. PubMed ID: 32011388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An artificial intelligence model to predict hepatocellular carcinoma risk in Korean and Caucasian patients with chronic hepatitis B.
    Kim HY; Lampertico P; Nam JY; Lee HC; Kim SU; Sinn DH; Seo YS; Lee HA; Park SY; Lim YS; Jang ES; Yoon EL; Kim HS; Kim SE; Ahn SB; Shim JJ; Jeong SW; Jung YJ; Sohn JH; Cho YK; Jun DW; Dalekos GN; Idilman R; Sypsa V; Berg T; Buti M; Calleja JL; Goulis J; Manolakopoulos S; Janssen HLA; Jang MJ; Lee YB; Kim YJ; Yoon JH; Papatheodoridis GV; Lee JH
    J Hepatol; 2022 Feb; 76(2):311-318. PubMed ID: 34606915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Application and Comparison of Machine Learning Models for the Prediction of Breast Cancer Prognosis: Retrospective Cohort Study.
    Xiao J; Mo M; Wang Z; Zhou C; Shen J; Yuan J; He Y; Zheng Y
    JMIR Med Inform; 2022 Feb; 10(2):e33440. PubMed ID: 35179504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HCC risk stratification after cure of hepatitis C in patients with compensated advanced chronic liver disease.
    Semmler G; Meyer EL; Kozbial K; Schwabl P; Hametner-Schreil S; Zanetto A; Bauer D; Chromy D; Simbrunner B; Scheiner B; Stättermayer AF; Pinter M; Schöfl R; Russo FP; Greenfield H; Schwarz M; Schwarz C; Gschwantler M; Alonso López S; Manzano ML; Ahumada A; Bañares R; Pons M; Rodríguez-Tajes S; Genescà J; Lens S; Trauner M; Ferenci P; Reiberger T; Mandorfer M
    J Hepatol; 2022 Apr; 76(4):812-821. PubMed ID: 34871626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a machine learning model to predict early recurrence for hepatocellular carcinoma after curative resection.
    Zeng J; Zeng J; Lin K; Lin H; Wu Q; Guo P; Zhou W; Liu J
    Hepatobiliary Surg Nutr; 2022 Apr; 11(2):176-187. PubMed ID: 35464276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metformin reduces hepatocellular carcinoma incidence after successful antiviral therapy in patients with diabetes and chronic hepatitis C in Taiwan.
    Tsai PC; Kuo HT; Hung CH; Tseng KC; Lai HC; Peng CY; Wang JH; Chen JJ; Lee PL; Chien RN; Yang CC; Lo GH; Kao JH; Liu CJ; Liu CH; Yan SL; Bair MJ; Lin CY; Su WW; Chu CH; Chen CJ; Tung SY; Tai CM; Lin CW; Lo CC; Cheng PN; Chiu YC; Wang CC; Cheng JS; Tsai WL; Lin HC; Huang YH; Yeh ML; Huang CF; Hsieh MH; Huang JF; Dai CY; Chung WL; Chen CY; Yu ML;
    J Hepatol; 2023 Feb; 78(2):281-292. PubMed ID: 36208843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Late development of hepatocellular carcinoma after viral clearance in patients with chronic hepatitis C: A need for continual surveillance.
    Tong MJ; Theodoro CF; Salvo RT
    J Dig Dis; 2018 Jul; 19(7):411-420. PubMed ID: 29889353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocellular Carcinoma after Achievement of Sustained Viral Response with Daclatasvir and Asunaprevir in Patients with Chronic Hepatitis C Virus Infection.
    Ida H; Hagiwara S; Kono M; Minami T; Chishina H; Arizumi T; Takita M; Yada N; Minami Y; Ueshima K; Nishida N; Kudo M
    Dig Dis; 2017; 35(6):565-573. PubMed ID: 29040989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors of hepatocellular carcinoma development in non-cirrhotic patients with sustained virologic response for chronic hepatitis C virus infection.
    Toyoda H; Kumada T; Tada T; Kiriyama S; Tanikawa M; Hisanaga Y; Kanamori A; Kitabatake S; Ito T
    J Gastroenterol Hepatol; 2015 Jul; 30(7):1183-9. PubMed ID: 25678094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A radiomics-based model can predict recurrence-free survival of hepatocellular carcinoma after curative ablation.
    Peng W; Jiang X; Zhang W; Hu J; Zhang Y; Zhang L
    Asian J Surg; 2023 Jul; 46(7):2689-2696. PubMed ID: 36351862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamics of cytokines predicts risk of hepatocellular carcinoma among chronic hepatitis C patients after viral eradication.
    Lu MY; Yeh ML; Huang CI; Wang SC; Tsai YS; Tsai PC; Ko YM; Lin CC; Chen KY; Wei YJ; Hsu PY; Hsu CT; Jang TY; Liu TW; Liang PC; Hsieh MY; Lin ZY; Chen SC; Huang CF; Huang JF; Dai CY; Chuang WL; Yu ML
    World J Gastroenterol; 2022 Jan; 28(1):140-153. PubMed ID: 35125824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.